ArticlePoultry science2026
The avian respiratory microenvironment-immune nexus: A three-dimensional regulation model from local homeostasis to systemic defense.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The avian respiratory tract is a major portal of entry for respiratory pathogens, and the dynamic interactions between the mucosal immune system and resident microbial communities constitute an important component of local defense. Although these interactions are increasingly recognized, substantial knowledge gaps remain regarding the molecular mediators of the gut-lung axis, the interplay between the microbiota and tissue-resident memory T (TRM) cells, and the mechanisms that maintain local homeostasis. This review synthesizes multidisciplinary advances in avian respiratory immunology and microbiome research. We distinguish direct evidence obtained in avian species from mechanisms inferred from mammalian studies and identify the latter as hypotheses requiring validation in birds. We discuss a putative regulatory axis linking dominant respiratory and intestinal microbial taxa, microbial metabolites such as short-chain fatty acids (SCFAs) and pyrroloquinoline quinone (PQQ), and mucosal immune effectors including secretory immunoglobulin A (sIgA) and interferon lambda 3 (IFN-λ3). We further examine the proposed pathways through which dysbiosis may contribute to the progression from local barrier disruption to systemic disease. Considering avian anatomical and immunological characteristics, including nasal-associated lymphoid tissue (NALT) and the absence of conventional draining lymph nodes in chickens and turkeys, we propose a host-microbiota-environment framework for organizing the determinants of respiratory homeostasis and disease susceptibility. Furthermore, we review the application of high-throughput sequencing and gene-editing technologies to target discovery and discuss the potential translation of microecological interventions into poultry production. Collectively, this review provides a conceptual basis for investigating avian respiratory microecology and supports the evaluation of microbiota-directed approaches as potential complements to vaccination, biosecurity, environmental management, and antimicrobial stewardship.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.